中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01763 中国同辐

未开盘 08-18 16:05:00

16.590

-0.030

-0.18%

最高16.640	最低16.100	成交量8.74万
今开16.640	昨收16.620	日振幅3.25%
总市值53.09亿	流通市值13.27亿	总股本3.20亿
成交额144.24万	换手率0.11%	流通股本7,997万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":16.59,"timestamp":1787040300129,"preClose":16.62,"halted":0,"volume":87400,"delay":0,"changeRate":-0.001805054151624617,"floatShares":79968800,"shares":320000000,"eps":1.02,"marketStatus":"未开盘","change":-0.03,"latestTime":"08-18 16:05:00","open":16.64,"high":16.64,"low":16.1,"amount":1442402,"amplitude":0.032491,"askPrice":16.88,"askSize":2200,"bidPrice":16.6,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":1.139076,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787103000000},"marketStatusCode":0,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":16.62,"dividendRate":0.021078,"openAndCloseTimeList":[[1787016600000,1787025600000],[1787029200000,1787040000000]],"volumeRatio":2.4689265599492485,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"1163432824","title":"中国同辐（01763）拟于8月28日召开董事会 审议2026年中期业绩及股息安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1163432824","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163432824?lang=zh_cn&edition=full","pubTime":"2026-08-14 19:01","pubTimestamp":1786705279,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司（01763）8月14日公告称，公司董事会已排期于2026年8月28日（星期五）召开会议，审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩，并同时考虑派发中期股息（如有）。\n公告显示，会议由董事长肖亚飞召集。目前，公司董事会成员包括：执行董事肖亚飞、张军旗、霍颖颖；非执行董事陈赞、丁建民、张国良、常晋峪；独立非执行董事潘昭国、陈景善、卢闯、安锐。\n","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154763805","title":"中国同辐（01763）发布补充公告：核医学发展中心评估价值1,840万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154763805","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154763805?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:21","pubTimestamp":1785849718,"startTime":"0","endTime":"0","summary":"2026年8月4日，中国同辐公布《关于设立合资公司股东协议的补充公告》，披露核医学发展中心的收益预测、成本预测、资本性支出及评估结果等关键信息。核医学发展中心主营业收入预计将由2024年的48.73万元逐步增长至2030年的6,394.22万元。其中，2026年至2030年期间分别预测为942.06万元、2,112.37万元、3,510.94万元、4,952.58万元及6,394.22万元。在此基础上，核医学发展中心的评估价值为1,840万元，较截至2025年9月30日账面净资产426.97万元增值1,413万元，增值率约330.9%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113421429","title":"中国同辐7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1113421429","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113421429?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:41","pubTimestamp":1785832893,"startTime":"0","endTime":"0","summary":"中国同辐(01763)于2026年8月4日披露了截至2026年7月31日的股份变动月报表。该报告期内，公司股本未发生增减变动，总股本保持不变。\n根据公告披露，截至2026年7月31日，中国同辐已发行普通股H股79,968,800股、内资股239,906,100股，两类股份合计319,874,900股。在已发行股份期间内，公司未进行新增发行、购回、注销或库藏股，股本构成与说明期初相同。此外，报告并未显示当月存在股份期权或股权激励计划的授予、行使及失效等变动情况。\n公告同时确认，公司已遵守香港联合交易所有限公司的相关上市规则及法律法规。本次月报由联席公司秘书王仓忍签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656328952","title":"港股异动 | 中国同辐(01763)涨超5% 近日与中核浙创成立合资公司中核辐智 将聚焦智慧核医疗产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2656328952","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656328952?lang=zh_cn&edition=full","pubTime":"2026-08-03 13:46","pubTimestamp":1785735991,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国同辐涨超5%，截至发稿，涨5.42%，报港17.13元，成交额149.4万港元。消息面上，近日，中国同辐发布公告，本公司与中核浙创订立《股东协议》，成立合资公司中核辐智。中核辐智成立后，本公司与中核浙创将分别持有中核辐智90%及10%的股权，中核辐智将成为本公司的非全资附属公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","KCAI","VXUS","01763","BK1222","159891","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655329568","title":"中国同辐斥资4500万元与关联方设立合资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2655329568","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655329568?lang=zh_cn&edition=full","pubTime":"2026-07-29 09:20","pubTimestamp":1785288000,"startTime":"0","endTime":"0","summary":"中国同辐（01763）发布公告，公司与关联方中核浙创于2026年7月28日订立股东协议，共同设立合资公司中核辐智（北京）科技有限公司，注册资本5000万元。公司出资4500万元，持股90%，中核辐智将成为公司的非全资附属公司。本次交易构成关连交易，因中核浙创为控股股东中核集团的全资附属公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607293824409865.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607293824409865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655183423","title":"港股公告掘金 | ASMPT中期股东应占盈利5.89亿港元，同比增长174.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655183423","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655183423?lang=zh_cn&edition=full","pubTime":"2026-07-29 09:01","pubTimestamp":1785286903,"startTime":"0","endTime":"0","summary":"重大事项：中国同辐(01763)与中核浙创订立《股东协议》，成立合资公司中核辐智南华期货股份(02691)境外子公司获得伦敦证券交易所非交易会员资格中集集团(02039)拟斥资1亿美元购买中集天达18.07%股权 持股比例增至83.73%中创新航(03931)拟6.9亿元收购中创新航科技(合肥)有限公司的12.7230%股权中国万天控股(01854)附属万天人工智能科技与星辰机器人订立战略合作框架","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0384037296.USD","BK1183","LU0648948544.HKD","LU0314109678.HKD","01763","BK1587","BK4585","LU0274383008.USD","09858","BK1614","BK1119","LU0417516738.SGD","LU1282649141.HKD","BK1147","LU0540923850.HKD","02039","IE0008369823.USD","SG9999000459.SGD","01958","LU0417516902.SGD","LU0227179875.USD","LU1813983027.USD","BK1212","LU0348766576.USD","VXUS","LU0348783233.USD","KCAI","LU1282649067.USD","BK1169","LU0348767384.USD","BK1222","BK1507","SG9999001903.USD","LU0348735423.USD","LU2039709279.SGD","LU0634319403.HKD","SG9999000475.SGD","LU0348784397.USD","LU1328277881.USD","BK1237","LU0348825331.USD","BK4588","LU0488056044.USD","02691","00522","LU1282649810.SGD","BK1539","LU0417516571.SGD","BK1589","MCHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148121722","title":"中国同辐（01763）4,500万元入股设立“中核辐智” 持股90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148121722","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148121722?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:50","pubTimestamp":1785250239,"startTime":"0","endTime":"0","summary":"2026年7月28日，中国同辐股份有限公司公告称，已与中核（浙江）科创有限公司签署《中核辐智（北京）科技有限公司股东协议》，共同出资设立合资公司中核辐智（北京）科技有限公司。其中，中国同辐拟出资4,500万元，占股90%，包括：。2）在2027年12月31日前以非货币方式出资1,840万元，对应为中国同辐核医学发展中心的净资产。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654883418","title":"中国同辐(01763.HK)与中核浙创订立《股东协议》，成立合资公司中核辐智","url":"https://stock-news.laohu8.com/highlight/detail?id=2654883418","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654883418?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:50","pubTimestamp":1785250205,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757299","title":"中国同辐(01763.HK)：用于前列腺癌诊断的氟[¹⁸F]司他明注射液顺利完成两项Ⅲ期临床试验参与者入组及数据管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653757299?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:56","pubTimestamp":1784721401,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107941123","title":"中国同辐(01763)公告：氟[¹⁸F]司他明注射液两项Ⅲ期临床试验完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1107941123","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107941123?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:56","pubTimestamp":1784721371,"startTime":"0","endTime":"0","summary":"2026年7月22日，中国同辐股份有限公司在香港联交所公告，其控股子公司原子高科股份有限公司已完成氟[F]司他明注射液两项Ⅲ期临床试验的受试者入组及数据管理工作。\\n\\n公告显示，两项多中心Ⅲ期临床试验分别针对中危初治和可疑复发的前列腺癌患者人群，验证了该药物的临床诊断效能与安全性。试验由中山大学肿瘤防治中心、北京大学第一医院牵头，联合多家国内权威临床研究中心开展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649768614","title":"中国同辐与中核原科成立合资公司中核辐原","url":"https://stock-news.laohu8.com/highlight/detail?id=2649768614","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649768614?lang=zh_cn&edition=full","pubTime":"2026-07-06 08:57","pubTimestamp":1783299420,"startTime":"0","endTime":"0","summary":"　　中国同辐公布，于2026年7月3日，公司与中核原科订立《股东协议》，成立合资公司中核辐原。根据《股东协议》，中核辐原的注册资本为人民币1，000万元，其中，公司将以货币方式出资人民币600万元，中核原科将以货币方式出资人民币400万元。中核辐原成立后，公司与中核原科将分别持有中核辐原60%及40%的股权，中核辐原将成为公司的非全资附属公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-06/doc-inifvkkf8846781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187952954","title":"中国同辐参设子公司中核福源 注册资本1000万元 公司出资600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187952954","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187952954?lang=zh_cn&edition=full","pubTime":"2026-07-03 21:49","pubTimestamp":1783086594,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司宣布，将与中核元科共同出资设立中核福源科技有限公司。新公司的注册资本为人民币1000万元，其中，中国同辐将出资人民币600万元，中核元科将出资人民币400万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178037280","title":"中国同辐与中核元科签署股东协议 共设合资企业中核辐源","url":"https://stock-news.laohu8.com/highlight/detail?id=1178037280","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178037280?lang=zh_cn&edition=full","pubTime":"2026-07-03 21:49","pubTimestamp":1783086593,"startTime":"0","endTime":"0","summary":"中国同辐宣布，已与中核元科签署股东协议，双方将共同出资设立合资企业，新公司定名为中核辐源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648669795","title":"中国同辐(01763)与中核原科成立合资公司中核辐原","url":"https://stock-news.laohu8.com/highlight/detail?id=2648669795","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648669795?lang=zh_cn&edition=full","pubTime":"2026-07-03 21:48","pubTimestamp":1783086530,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 公布，于2026年7月3日，公司与中核原科订立《股东协议》，成立合资公司中核辐原。根据《股东协议》，中核辐原的注册资本为人民币1,000万元，其中，公司将以货币方式出资人民币600万元，中核原科将以货币方式出资人民币400万元。中核辐原成立后，公司与中核原科将分别持有中核辐原60%及40%的股权，中核辐原将成为公司的非全资附属公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190853908","title":"中国同辐6月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1190853908","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190853908?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:54","pubTimestamp":1783068890,"startTime":"0","endTime":"0","summary":"中国同辐（01763）于2026年7月3日提交了截至2026年6月30日的股份变动月报表，数据显示公司本月无新增发行或库藏股变动，股本保持稳定。\n报告期内，公司普通股共分为H股与内资股两类。其中，H股数量为79,968,800股，内资股数量为239,906,100股，合计已发行股本和注册股本分别为319,874,900股与人民币319,874,900元，均与上月底持平，未见增减。此外，本期无股份购回、注销、期权或任何其他股份引起的股本增加或减少。\n公司确认，已遵守香港联交所《上市规则》及其他相关监管规定，本月无新增股份发行、回购或注销计划。本次公告由公司联席公司秘书王仓忍签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645701430","title":"中国同辐将于8月17日派发末期股息每股0.2264元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645701430","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645701430?lang=zh_cn&edition=full","pubTime":"2026-06-22 08:22","pubTimestamp":1782087720,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　中国同辐（01763）发布公告，该公司将于2026年8月17日派发末期股息每股0.2264元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-06-22/doc-iniefuxz7107887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK1222","01763","VIG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644508216","title":"中国同辐(01763)将于8月17日派发末期股息每股0.2264元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644508216","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644508216?lang=zh_cn&edition=full","pubTime":"2026-06-18 23:13","pubTimestamp":1781795638,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，该公司将于2026年8月17日派发末期股息每股0.2264元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","01763","VIG","BK1222","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170449330","title":"中国同辐宣派末期股息每股0.2264元，派息日8月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=1170449330","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170449330?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:55","pubTimestamp":1781794558,"startTime":"0","endTime":"0","summary":"中国同辐发布更新公告，将截至2025年12月31日止年度的末期股息定为每股0.2264元人民币。公司预设派发货币为港元，折合每股0.2604港元，汇率按1人民币兑1.150356港元计算。除净日定为2026年6月23日，为符合获取股息分派而递交股份过户文件的最后时限为6月24日16:30。股份过户登记将自6月25日至6月30日暂停办理，权益登记日为6月30日。股息最终派发日为2026年8月17日。代扣所得税方面，非中国内地登记地址的非居民企业股东将按10%税率代扣企业所得税。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中国同辐宣派末期股息每股0.2264元，派息日8月17日","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129735433","title":"中国同辐宣派末期股息每股0.2264元，预计8月17日前派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1129735433","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129735433?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:35","pubTimestamp":1781793342,"startTime":"0","endTime":"0","summary":"中国同辐(01763)公布，2025年度股东会已审议批准派发截至2025年12月31日止年度的末期股息，每股人民币0.2264元（含税），合计派发约7241.97万元。\n此次股息将以人民币向內资股持有人支付，H股持有人则按港元收取。H股股息换算汇率为中国人民银行于年度股东会日期前五个工作日港元兑人民币平均中间价（1.00港元兑人民币0.869296元），折算后每股H股派发0.2604港元（含税）。公司预计将于2026年8月17日（星期一）前向全体股东完成派发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国同辐宣派末期股息每股0.2264元，预计8月17日前派发","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644587084","title":"中国同辐(01763)委任张国良为董事会法治委员会委员","url":"https://stock-news.laohu8.com/highlight/detail?id=2644587084","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644587084?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:32","pubTimestamp":1781793137,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，于2026年6月18日，董事会决议委任张国良先生为董事会法治委员会委员及董事会科技创新委员会委员，任期至第四届董事会届满之日止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":-0.036},{"period":"1month","weight":-0.0125},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1802},{"period":"1year","weight":-0.0647},{"period":"ytd","weight":-0.1672}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":0.037},{"period":"3month","weight":-0.007},{"period":"6month","weight":-0.0462},{"period":"1year","weight":0.0117},{"period":"ytd","weight":-0.0062}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.035439},{"month":2,"riseRate":0.5,"avgChangeRate":0.038778},{"month":3,"riseRate":0.375,"avgChangeRate":-0.034565},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018502},{"month":5,"riseRate":0.5,"avgChangeRate":0.007801},{"month":6,"riseRate":0.5,"avgChangeRate":0.047136},{"month":7,"riseRate":0.25,"avgChangeRate":-0.02894},{"month":8,"riseRate":0.555556,"avgChangeRate":0.036629},{"month":9,"riseRate":0.125,"avgChangeRate":-0.029077},{"month":10,"riseRate":0.625,"avgChangeRate":-0.037451},{"month":11,"riseRate":0.75,"avgChangeRate":0.064372},{"month":12,"riseRate":0.5,"avgChangeRate":0.001665}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}